← Leaderboards
Luke Hilbert Hoeppner
Mayo Clinic Rochester
$878,191
Attributed
$878,191
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2014–17$250K$187.5K$125K$62.5K$0
'14
'15
'16
'17
Funding mix
By agency
NIH$878,191 · 2
By mechanism
R00$743,268 · 1
K99$134,923 · 1
Top collaborators
No co-investigators on record.
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Sujit Basu$9,062,631
- Fergus Joseph Couch$34,303,973
- Harry H Yoon$3,119,133
- Kah-Whye Peng$11,311,466
- Paul John Galardy$1,616,689
Others in their field
Top investigators on “Adenocarcinoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$39,462,948
- Anirban Maitra · Johns Hopkins University$30,605,004
- Richard M Peek · Vanderbilt University Medical Center$23,246,493
- Gloria M. Petersen · Johns Hopkins University$21,134,227
- Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr$19,098,764
- Dean E. Brenner · University Of Michigan At Ann Arbor$18,393,816
Research focus
AdenocarcinomaCessation Of LifeAlternative SplicingAmericanAngiogenesisAgonistAnimal ModelAntiangiogenesis TherapyAnticancer ResearchAntineoplastic AgentsAptitudeBaseBiochemistryBiological MarkersBreastCabergolineCancer BiologyCancer CellCancer PatientCancer TherapyCareerCause Of DeathCell GrowthChemotherapeutic Agent
Grant awards (4)
Triggering the dopamine pathway to inhibit lung cancer progression$249,000
R00 · FY2017 · CA · contact PI
Triggering the dopamine pathway to inhibit lung cancer progression$245,268
R00 · FY2016 · CA · contact PI
Triggering the dopamine pathway to inhibit lung cancer progression$249,000
R00 · FY2015 · CA · contact PI
Triggering the dopamine pathway to inhibit lung cancer progression$134,923
K99 · FY2014 · CA · contact PI